ALLO Competitors & Alternatives

Compare Allogene Therapeutics Inc with similar stocks in the same industry

Biotechnology

ALLO

Main Stock
$2.09
Tradestie Score
46
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+330.6%

Top Competitors

238 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OLMA Olema Pharmaceuticals, Inc. Common Stock
$10.69
$757.72M - 49 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$29.12
$748.90M - 58 Compare
TBPH Theravance Biopharma, Inc.
$17.01
$726.21M 16.3 50 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$26.72
$718.62M - 35 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$26.05
$715.25M - 62 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 51 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$142.04
$699.30M - 40 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$6.91
$688.47M - 38 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 49 Compare
ARVN Arvinas, Inc
$9.37
$670.30M 37.6 41 Compare

Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)

238 stocks in this industry